By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French biotech Genoway said today it has licensed technology from Bluebird Bio to genetically modify rodents.

The license grants Genoway exclusive worldwide rights to Bluebird's RCME technology, which combines a recombinase system with genetic modification, enabling the introduction of a DNA sequence at a specific locus. The technology was developed at the Massachusetts Institute of Technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.